Observatoire des droits humains (anglais seulement)

'Pretty Good' Malaria Vaccine Moves Forward

(Version anglaise seulement)

A “pretty good” malaria vaccine is on track to be the first to market. It only prevents infection about one-quarter to one-half the time, so it’s not as good as most vaccines. But for a disease like malaria, which kills 600,000 people a year, “pretty good” may be good enough. GlaxoSmithKline has applied for regulatory approval for its RTS,S vaccine. Partial protection A new 18-month study in the journal PLoS Medicine shows the vaccine prevented 46 percent of malaria illnesses in...

Lire l'article complet